APP and Alzheimer disease: As observed in patients with AD [20], ageing APPSWE/PS1ΔE9 (APP/PS1)-transgenic mice [21] progressively accumulate amyloid-β (Aβ) in their cortex [22] and have reduced density of 5-HTergic fibres and reduced levels of 5-HT [23].